On April 4, 2019 RedHill Biopharma Ltd. (Nasdaq: RDHL) (Tel-Aviv Stock Exchange: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company primarily focused on gastrointestinal diseases, reported that the Company will present at three conferences in April (Press release, RedHill Biopharma, APR 4, 2019, View Source [SID1234535014]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

H.C. Wainwright Global Life Sciences Conference
Date: Tuesday, April 9, 2019, 11:30 a.m. GMT
Content: Corporate overview
Speaker: Guy Goldberg, chief business officer
Location: JW Marriott Grosvenor House, London, Spencer Suite
Live Webcast: View Source
The webcast will be available via replay for 30 days on the Company’s website.

BioCentury’s Future Leaders in the Biotech Industry Conference
Date: Friday, April 12, 2019, 9:00 a.m. EDT
Content: Corporate overview
Speaker: Dror Ben-Asher, chief executive officer
Location: Millennium Broadway Hotel & Conference Center, New York

World Orphan Drug Congress USA 2019
Date: Friday, April 12, 2019, 3:10 p.m. EDT
Content: YELIVA (opaganib) for cholangiocarcinoma and RHB-204 for pulmonary nontuberculous mycobacteria (NTM) infections
Speaker: Patricia Anderson, vice president regulatory affairs
Location: Gaylord National Harbor Hotel, Oxon Hill, MD